Patents by Inventor Meaghan Valliere

Meaghan Valliere has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOSYNTHETIC PRODUCTION OF 2-FUCOSYLLACTOSE
    Publication number: 20240093255
    Abstract: The present invention provides a novel biosynthetic production process which converts L-galactose into 2?-fucosyllactose via four enzymatically catalyzed reaction steps. The present process is designed such that co-factors required by the process are regenerated within the four reaction steps, hence making the process cost-effective and efficient. The process can be performed in vitro in a cell-free system. The present invention also provides mutant enzymes that can be used to increase production levels of 2?-fucosyllactose, whether using the novel pathway described herein or the mannose-dependent pathway known in the art.
    Type: Application
    Filed: February 17, 2023
    Publication date: March 21, 2024
    Applicant: Conagen Inc.
    Inventors: Guohong Mao, Meaghan Valliere, Johnson Wu, Oliver Yu, Sean Robert Johnson
  • BIOSYNTHETIC PLATFORM FOR THE PRODUCTION OF CANNABINOIDS AND OTHER PRENYLATED COMPOUNDS
    Publication number: 20230348866
    Abstract: Provided is an enzyme useful for prenylation and recombinant pathways for the production of cannabinoids, cannabinoid precursors and other prenylated chemicals in a cell free system as well and recombinant microorganisms that catalyze the reactions.
    Type: Application
    Filed: December 24, 2020
    Publication date: November 2, 2023
    Inventors: James U. Bowie, Tyler P. Korman, Meaghan Valliere
  • BIOSYNTHETIC PLATFORM FOR THE PRODUCTION OF CANNABINOIDS AND OTHER PRENYLATED COMPOUNDS
    Publication number: 20230193221
    Abstract: Provided is an enzyme useful for prenylation and recombinant pathways for the production of cannabinoids, cannabinoid precursors and other prenylated chemicals in a cell free system as well and recombinant microorganisms that catalyze the reactions.
    Type: Application
    Filed: October 24, 2022
    Publication date: June 22, 2023
    Inventors: James U. Bowie, Meaghan Valliere, Tyler P. Korman, Nicholas Woodall
  • Biosynthetic platform for the production of cannabinoids and other prenylated compounds
    Patent number: 11479760
    Abstract: Provided is an enzyme useful for prenylation and recombinant pathways for the production of cannabinoids, cannabinoid precursors and other prenylated chemicals in a cell free system as well and recombinant microorganisms that catalyze the reactions.
    Type: Grant
    Filed: August 1, 2019
    Date of Patent: October 25, 2022
    Assignee: The Regents of the University of California
    Inventors: James U. Bowie, Meaghan Valliere, Tyler P. Korman, Nicholas Woodall
  • BIOSYNTHETIC PLATFORM FOR THE PRODUCTION OF CANNABINOIDS AND OTHER PRENYLATED COMPOUNDS
    Publication number: 20210309975
    Abstract: Provided is an enzyme useful for prenylation and recombinant pathways for the production of cannabinoids, cannabinoid precursors and other prenylated chemicals in a cell free system as well and recombinant microorganisms that catalyze the reactions.
    Type: Application
    Filed: August 1, 2019
    Publication date: October 7, 2021
    Inventors: James U. Bowie, Meaghan Valliere, Tyler P. Korman, Nicholas Woodall